RLMD · Relmada Therapeutics, Inc. · Proposed Sales
$3.77
+0.04 (+1.07%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$408.55M
Shares
106.67M
Volume · Sep 30
999.53K
Avg daily vol (3M)
1.36M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.